loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations
Open ICICI 3-in-1 Account

BSE Hospitals Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Artemis Medicare Services Ltd. 11 May 2026 12:16 PM
Result PDF

Q4FY26 & FY26 Result Announced for Artemis Medicare Services Ltd.

Healthcare Facilities company Artemis Medicare Services announced Q4FY26 & FY26 results

Q4FY26 Financial Highlights:

  • Revenue from operations up by 16.4% at Rs 27,923 lakh, against Rs 23,990 lakh.
  • EBITDA of Rs 5,938 lakh against Rs 4,824 lakh, growth of 23.1%.
  • PAT of Rs 3,028 lakh against Rs 2,292 lakh, growth of 32.1%.

FY26 Financial Highlights:

  • Revenue from operations up by 15.4% at Rs 1,08,124 lakh, against Rs 93,692 lakh.
  • EBITDA of Rs 21,801 lakh against Rs 18,478 lakh, growth of 18.0%.
  • PAT of Rs 10,372 lakh against Rs 8,218 lakh, growth of 26.2%.

Business Highlights:

  • Performance Highlights Artemis Hospital Gurgaon:
    • Average revenue per occupied bed (ARPOB) at Rs 82,435, against Rs 76,447.
    • Revenue from operations up by 17.8% at Rs 1,03,022 lakh, against Rs 87,424 lakh.
    • EBITDA of Rs 21,785 lakh against Rs 18,590 lakh, growth of 17.2%.
    • PAT of Rs 11,336 lakh against Rs 9,837 lakh, growth of 15.2%.
    • Bed capacity utilisation stood at 63.0%.
    • Revenue from overseas patients increased by 26.9% to Rs 32,268 lakh from Rs 25,433 lakh.
    • Overseas patients contributed 31.3% to Net Revenue.
    • Average length of stay (ALOS) remains constant at 3.6 days

Onkar Kanwar, Chairman, Artemis Medicare Services, said “We are pleased with our performance in Q4FY26, which reflects steady progress and consistent execution across our operations. The year has been marked by sustained growth, improving profitability, and continued focus on delivering high-quality clinical outcomes and patient experience.

Our flagship Gurugram facility remained a key driver of performance, supported by a strong case mix, stable occupancy, and growing contribution from international patients. This underscores our positioning in high-acuity care and our continued strength in the Medical Value Travel segment.”

Devlina Chakravarty, Managing Director, Artemis Medicare Services, said: “Operational discipline and ongoing efficiency initiatives have supported improved profitability during the year, while ensuring that patient care and clinical outcomes remain at the core of our approach.

On the expansion front, we are making good progress on our upcoming Raipur facility, which represents an important step in extending our presence into new, high-growth markets. Going ahead, we will continue to focus on strengthening our clinical capabilities, enhancing operational efficiencies, and pursuing calibrated expansion, with the objective of building a resilient and future-ready healthcare platform.”

Result PDF

Result PDF

Healthcare Facilities company Aster DM Healthcare announced Q4FY26 results

  • Revenue for Q4FY26 grew 18% YoY to Rs 1,182 crore.
  • Operating EBITDA (ex-Kasaragod) grew 31% YoY to Rs 253 crore in Q4FY26.
  • Operating EBITDA Margins (ex-Kasaragod) stood at 21.7% in Q4FY26 vs. 19.3% in Q4FY25.
  • Normalised PAT1 (ex-Kasaragod) grew 45% YoY to Rs 153 crore In Q4FY26.

Azad Moopen, Founder & Chairman, Aster DM Healthcare, said: “We are very pleased that the merger of Aster DM Healthcare and Quality Care India Limited (QCIL), in partnership with Blackstone, is progressing towards completion in Q1FY27. The overwhelming shareholder support, with 96.68% votes in favour, reflects strong confidence in our vision of building a scaled and integrated healthcare platform. On a proforma basis, Q4FY26 revenues grew 18% YoY to Rs 2,361 crore, while operating EBITDA increased 25% YoY to Rs 517 crore, supported by strong growth in patient volumes, and continued margin expansion.

The combined entity will have a capacity of over 10,623 beds across 28 cities, with an additional pipeline of around 4,445 beds, providing clear visibility to exceed 15,500 beds in the near term, thus . This positions the platform to become one of the top three healthcare providers in India.”

“Our performance this quarter reflects consistent execution, with revenues growing 18% YoY to Rs 1,182 crore. Excluding the impact of the newly commissioned Kasargod facility, operating EBITDA grew 31% YoY, with margins improving to 21.7%, driven by operating leverage and disciplined cost management.”

Result PDF

Healthcare Facilities company Narayana Hrudayalaya announced Q3FY26 results

  • Revenue from operations: Rs 21,511.7 million against Rs 13,345.9 million during Q3FY25, change 61%.
  • PBT: Rs 1,503.56 million against Rs 2,195.46 million during Q3FY25, change -32%.
  • PAT: Rs 1,280.86 million against Rs 1,936.41 million during Q3FY25, change -34%.
  • EPS: Rs 6.24 for Q3FY26.

Result PDF

Healthcare Facilities company Apollo Hospitals Enterprise announced Q3FY26 results

  • Revenue: Rs 64,774 million against Rs 55,269 million during Q3FY25, change 17%.
  • EBITDA: Rs 9,653 million against Rs 7,615 million during Q3FY25, change 27%.
  • EBITDA Margin: 14.9% for Q3FY26.
  • PBT: Rs 6,820 million against Rs 5,362 million during Q3FY25, change 27%.
  • PBT Margin: 10.5% for Q3FY26.
  • PAT: Rs 5,215 million against Rs 3,723 million during Q3FY25, change 40%.

Result PDF

Healthcare Services company Kovai Medical Center and Hospital announced Q3FY26 results

  • Revenue: Rs 40,661.98 lakh against Rs 35,469.58 lakh during Q3FY25, change 15%.
  • PBT: Rs 8,713.92 lakh against Rs 7,512.97 lakh during Q3FY25, change 16%.
  • PAT: Rs 6,501.99 lakh against Rs 5,780.37 lakh during Q3FY25, change 12%.
  • EPS: Rs 59.42 for Q3FY26.

Result PDF

Healthcare Facilities company Krishna Institute of Medical Sciences announced Q3FY26 results

  • Consolidated Revenue from Operations of Rs 998 crore, a growth of 29.2% on YoY and 3.9% on QoQ basis.
  • Consolidated EBITDA(Pre-INDAS) of Rs 193 crore, adegrowth of 2.2% on YoY and a degrowth of 3.7% on QoQ basis.
  • Consolidated EBITDA (Pre-INDAS and excluding Other Income) of Rs 188 crore, a growth of 4.6% and a degrowth of 4.3% on YoY and QoQ basis respectively.

B Bhaskar Rao, CMD, KIMS Hospitals, said: The third quarter has seen a lot of progress for us. We have seen patient footfalls steadily increasing at all our centers. I am particularly pleased to see both our Bangalore units and Thane unit steadily ramping up on clinical and non-clinical parameters. I am optimistic that we are on course to have a healthy closure to FY26.”

Result PDF

Healthcare Facilities company Healthcare Global Enterprises announced Q3FY26 results

  • Revenue: Rs 6,312 million against Rs 5,576 million during Q3FY25, change 13%.
  • EBITDA: Rs 1,108 million against Rs 923 million during Q3FY25, change 20%.
  • EBITDA Margin: 16.5% for Q3FY26.
  • PBT: Rs -61 million against Rs -33 million during Q3FY25, change -85%.
  • PAT: Rs -94 million against Rs 70 million during Q3FY25, change -234%.
  • PAT Margin: 1.2% for Q3FY26.
  • EPS: Rs 0.5 for Q3FY26.

Result PDF

Healthcare Facilities company Yatharth Hospital & Trauma Care Services announced Q3FY26 results

  • Revenue: Rs 3,205 million against Rs 2,192 million during Q3FY25, change 46%.
  • EBITDA: Rs 742 million against Rs 549 million during Q3FY25, change 35%.
  • EBITDA Margin: 23.2% for Q3FY26.
  • PAT: Rs 431 million against Rs 305 million during Q3FY25, change 41%.

Yatharth Tyagi, Whole Time Director, Yatharth Hospitals, said: “We are pleased to report an industry leading performance this quarter, with highest ever growth. This highlights our ability to successfully acquire, integrate, and scale new assetsrapidly. Our newly operationalised hospitals at Model Town, New Delhi and Faridabad Sec-20 contributed 9% to the Group’s revenues within their first full quarter of operations, driven 100% by Cash and TPA patients and 0% Government Business, supporting our strategic focus on improving payer mix. The Agra facility, integrated from February 2026, is expected to contribute meaningfully from this quarter. The Greater Faridabad hospital has turned profitable and is now adding significantly to Group financials, reflecting strong execution, brand recall, star doctor onboarding, and clinical excellence. With a strong execution engine in place, we remain confident of sustaining the accelerated growth and long-term value creation for all our stakeholders.”

Result PDF

Healthcare Facilities company Max Healthcare Institute announced Q3FY26 results

  • Gross Revenue stood at Rs 2,608 crore for Q3FY26, a growth of 10% YoY.
  • Network Operating EBITDA stood at Rs 648 crore in Q3FY26, a growth of 4% YoY.
  • Operating Margin stood at 26.1% compared to 27.3% in Q3FY25 and 26.9% in Q2FY26.
  • Network PAT stood at Rs 344 crore, compared to Rs 316 crore in Q3FY25 and Rs 554 crore in Q2FY26, reflecting a growth of 9% YoY. PAT is after expense of Rs 55 crore towards two exceptional items i.e. impact of Code on Wages, 2019 and provision for stamp duty on the amalgamation of Crosslay Remedies Ltd (CRL) with Jaypee Healthcare Ltd (JHL).
  • Free Cash from Operations was Rs 281 crore in Q3FY26 compared with Rs 303 crore in Q3FY25 and Rs 291 crore in Q2FY26.
  • EBITDA per bed4 was Rs 71.3 lakh compared to Rs 73.0 lakh in Q3FY25 and Rs 73.4 lakh in Q2FY26.
  • Bed occupancy for the quarter was at 74%, with Occupied Bed Days (OBDs) up by 7% YoY.
  • ARPOB 5 for Q3FY26 stood at Rs 77.9k compared to Rs 75.9k in Q3FY25 and Rs 77.3k in Q2FY26.
  • Free treatment provided to 38,915 patients in OPD and 1,568 patients in IPD from the economically weaker sections by the Network Hospitals.
  • The Company executed a Share Purchase Agreement for staggered acquisition of 100% equity stake in Yerawada Properties Pvt. Ltd. (YPPL) for developing a ~450 beds hospital, on a land parcel in prime location in Pune.
  • 160 beds MSSH Mohali brownfield tower: 53 beds commissioned with current occupancy of 46 beds delivering an EBITDA margin of ~39%. Balance beds will be commissioned by February end.
  • 280 beds Nanavati Max brownfield tower: 63 beds commissioned with current occupancy of 45 beds delivering an EBITDA margin of ~31%. Balance beds to be commissioned by March end.
  • 400 beds Max Smart brownfield tower: expected commissioning by February end in a phased manner, upon receipt of regulatory approvals.
  • The Board approved the brownfield expansion of the existing MSSH Dwarka facility to include 260 additional beds, to be constructed by the partner, taking the overall capacity to 560 beds.

Abhay Soi, Chairman & Managing Director, Max Healthcare Institute, said: “We are privileged to have treated over 40K patients free of cost in this quarter. We also continued our steady performance this quarter with Revenue and PAT growth of 10% and 9%, respectively. More importantly, we have operationalised new brownfield beds at Nanavati Max and MSSH Mohali, which have demonstrated accretive margins already. We expect a significant ramp up in our capacity in Q4 and in FY27. Encouraging performance in existing network hospitals and new capacity additions has boosted our confidence to further pursue growth opportunities, including our entry into Pune.”

Result PDF

Healthcare Facilities company Global Health announced Q3FY26 results

  • Revenue: Rs 11,210.47 million against Rs 9,434.36 million during Q3FY25, change 19%.
  • PBT: Rs 1,197.83 million against Rs 1,890.68 million during Q3FY25, change -37%.
  • PAT: Rs 950.33 million against Rs 1428.58 million during Q3FY25, change -33%.
  • EPS: Rs 3.54 for Q3FY26.

Result PDF

Trending News

L&T bags ₹1,000–2,500cr EPC order for Odisha Coal-to-Ammonium-Nitrate project

Larsen & Toubro Limited secured a significant EPC order (₹1,000–2,500 crore) from Bharat Coal Gasification and Chemicals Limited, a JV of Coal India Limited and Bharat Heavy Electricals Limited, for a Coal-to-Ammonium-Nitrate project in Odisha. 

Published on 11-May-2026 09:21

NTPC to submit first nuclear feasibility study to DAE; eyes 30GW capacity across India by 2047

NTPC Limited is set to submit its first feasibility study for a standalone nuclear power project to the Department of Atomic Energy (DAE), marking a key step in its nuclear expansion plans. 

Published on 11-May-2026 09:20

Tata Consumer Q4: Revenue Jumps 18% to ₹5,434Cr, Net Profit Up 21% as India Growth Businesses Shine

Tata Consumer Products (TCPL)’s consolidated revenues and EBITDA strong double-digit growth in Q4FY26. 

Published on 11-May-2026 09:19

Titan Q4 Revenue Surges 48% to ₹20,607Cr on Jewellery Demand; Margins Squeeze 311bps to 7.2%

Titan Company Ltd’s consolidated revenues grew by 48.3% YoY to Rs.20,607cr driven by 48% YoY growth in domestic jewellery (ex-bullion) and 21% YoY growth in Caratlane business. 

Published on 11-May-2026 09:18

Hyundai India Q4: 22% PAT Drop to ₹1,256Cr on Margin Pressure, Sales Volume Up 8.7% YoY

Hyundai Motor India reported steady performance in Q4FY26. Sales volume for the quarter stood at 2.08 lakh units, up 8.7% YoY. 

Published on 11-May-2026 09:17

JSW Steel Wins Goa’s Pissurlem Mineral Block in Auction with 118% Bid, 96MT Iron Ore Resource

As per media sources, JSW Steel has been declared as the preferred bidder for the Pissurlem Mineral Block No. XV in Goa, following the auction process, with the highest final offer price of 118.10% of the value of mineral dispatched. 

Published on 11-May-2026 09:16

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app